 Felipe Valenca Pereira
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma, Experimental | 6 | 2019 | 111 | 1.100 |
Why?
| | STAT3 Transcription Factor | 2 | 2021 | 203 | 0.880 |
Why?
| | Interleukin-6 | 2 | 2021 | 785 | 0.580 |
Why?
| | Cell Movement | 2 | 2021 | 969 | 0.570 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2019 | 155 | 0.520 |
Why?
| | Organometallic Compounds | 2 | 2019 | 112 | 0.440 |
Why?
| | Antineoplastic Agents | 6 | 2021 | 2153 | 0.430 |
Why?
| | Apoptosis | 4 | 2013 | 2552 | 0.390 |
Why?
| | Mitochondria | 4 | 2021 | 958 | 0.370 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2021 | 184 | 0.370 |
Why?
| | Mice, Inbred C57BL | 11 | 2021 | 5805 | 0.370 |
Why?
| | Mitochondrial Proteins | 3 | 2020 | 258 | 0.350 |
Why?
| | beta 2-Microglobulin | 1 | 2021 | 50 | 0.340 |
Why?
| | Interferon-gamma Release Tests | 1 | 2021 | 32 | 0.340 |
Why?
| | Adenovirus Vaccines | 1 | 2020 | 2 | 0.320 |
Why?
| | Melanoma | 2 | 2020 | 757 | 0.310 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2021 | 1098 | 0.310 |
Why?
| | Antigens, Surface | 1 | 2020 | 154 | 0.310 |
Why?
| | Tellurium | 1 | 2019 | 4 | 0.310 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 68 | 0.300 |
Why?
| | Mice | 14 | 2021 | 17836 | 0.290 |
Why?
| | Virus Diseases | 1 | 2021 | 214 | 0.290 |
Why?
| | Recombinant Fusion Proteins | 1 | 2021 | 663 | 0.280 |
Why?
| | Cell Line, Tumor | 8 | 2021 | 3399 | 0.260 |
Why?
| | Neoplasm Metastasis | 3 | 2014 | 667 | 0.260 |
Why?
| | Mesenteric Arteries | 1 | 2016 | 17 | 0.260 |
Why?
| | Aldosterone | 1 | 2016 | 42 | 0.260 |
Why?
| | Galactosylceramides | 1 | 2016 | 25 | 0.250 |
Why?
| | Dendritic Cells | 1 | 2020 | 491 | 0.250 |
Why?
| | Lipid A | 1 | 2016 | 28 | 0.250 |
Why?
| | Animals | 17 | 2021 | 37261 | 0.240 |
Why?
| | Lymphocytes | 1 | 2018 | 396 | 0.240 |
Why?
| | Flagellin | 1 | 2014 | 17 | 0.220 |
Why?
| | Serratia | 1 | 2014 | 3 | 0.220 |
Why?
| | Matrix Metalloproteinase 8 | 1 | 2014 | 8 | 0.220 |
Why?
| | Metalloproteases | 1 | 2014 | 42 | 0.210 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2021 | 911 | 0.210 |
Why?
| | Toll-Like Receptor 4 | 1 | 2016 | 275 | 0.210 |
Why?
| | Antigens, Bacterial | 1 | 2014 | 125 | 0.210 |
Why?
| | HSP40 Heat-Shock Proteins | 2 | 2021 | 27 | 0.210 |
Why?
| | Propylene Glycols | 1 | 2013 | 27 | 0.200 |
Why?
| | Lung Neoplasms | 4 | 2014 | 2533 | 0.200 |
Why?
| | Sphingosine | 1 | 2013 | 45 | 0.200 |
Why?
| | Cancer Vaccines | 1 | 2014 | 166 | 0.200 |
Why?
| | Killer Cells, Natural | 1 | 2016 | 461 | 0.190 |
Why?
| | Glycoproteins | 1 | 2014 | 354 | 0.190 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 699 | 0.190 |
Why?
| | Antibodies, Neoplasm | 1 | 2012 | 33 | 0.190 |
Why?
| | Immunoglobulin Variable Region | 1 | 2012 | 79 | 0.180 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2012 | 83 | 0.180 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 96 | 0.180 |
Why?
| | Anacardiaceae | 1 | 2011 | 4 | 0.180 |
Why?
| | Monoterpenes | 1 | 2011 | 16 | 0.180 |
Why?
| | Palladium | 1 | 2011 | 18 | 0.180 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2021 | 121 | 0.170 |
Why?
| | Peptide Fragments | 1 | 2014 | 694 | 0.170 |
Why?
| | Immunotherapy | 1 | 2014 | 633 | 0.160 |
Why?
| | Actins | 1 | 2012 | 419 | 0.160 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2021 | 801 | 0.150 |
Why?
| | HLA-A2 Antigen | 2 | 2021 | 49 | 0.150 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 433 | 0.150 |
Why?
| | Adenosine Triphosphate | 1 | 2021 | 490 | 0.150 |
Why?
| | Cytokines | 2 | 2021 | 2084 | 0.150 |
Why?
| | Molecular Chaperones | 1 | 2020 | 196 | 0.140 |
Why?
| | Immunosuppressive Agents | 1 | 2013 | 849 | 0.140 |
Why?
| | Flow Cytometry | 3 | 2019 | 1193 | 0.140 |
Why?
| | Lymphocyte Activation | 1 | 2021 | 1148 | 0.130 |
Why?
| | Fatty Acids | 1 | 2020 | 445 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 264 | 0.130 |
Why?
| | Signal Transduction | 3 | 2021 | 5095 | 0.120 |
Why?
| | Mice, Knockout | 3 | 2019 | 3029 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 850 | 0.120 |
Why?
| | Calcium | 1 | 2021 | 1189 | 0.120 |
Why?
| | Mice, SCID | 2 | 2021 | 368 | 0.120 |
Why?
| | Caspase 1 | 2 | 2016 | 146 | 0.110 |
Why?
| | Diet, High-Fat | 2 | 2020 | 247 | 0.110 |
Why?
| | Mice, Inbred NOD | 2 | 2021 | 593 | 0.110 |
Why?
| | Skin Neoplasms | 1 | 2011 | 838 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2021 | 1994 | 0.100 |
Why?
| | Mice, Transgenic | 2 | 2021 | 2172 | 0.100 |
Why?
| | Male | 10 | 2021 | 68299 | 0.100 |
Why?
| | Cell Survival | 2 | 2019 | 1126 | 0.100 |
Why?
| | Reactive Oxygen Species | 2 | 2016 | 627 | 0.090 |
Why?
| | Liver | 1 | 2020 | 1807 | 0.090 |
Why?
| | Interferon-gamma | 2 | 2016 | 787 | 0.090 |
Why?
| | Caspase 3 | 2 | 2013 | 251 | 0.090 |
Why?
| | Membrane Potential, Mitochondrial | 2 | 2011 | 73 | 0.090 |
Why?
| | HIV Core Protein p24 | 1 | 2021 | 32 | 0.090 |
Why?
| | Mice, Obese | 1 | 2020 | 67 | 0.080 |
Why?
| | Thrombomodulin | 1 | 2020 | 10 | 0.080 |
Why?
| | Cathepsin L | 1 | 2019 | 9 | 0.080 |
Why?
| | Cathepsin B | 1 | 2019 | 14 | 0.080 |
Why?
| | Stereoisomerism | 1 | 2019 | 106 | 0.070 |
Why?
| | Th1 Cells | 1 | 2019 | 140 | 0.070 |
Why?
| | Leptin | 1 | 2020 | 242 | 0.070 |
Why?
| | Th17 Cells | 1 | 2019 | 108 | 0.070 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2019 | 107 | 0.070 |
Why?
| | Actin Cytoskeleton | 1 | 2019 | 103 | 0.070 |
Why?
| | Macrophages | 2 | 2016 | 1544 | 0.070 |
Why?
| | Cell Adhesion | 1 | 2019 | 466 | 0.070 |
Why?
| | Humans | 11 | 2021 | 139072 | 0.070 |
Why?
| | Nigericin | 1 | 2016 | 2 | 0.070 |
Why?
| | Plasmodium yoelii | 1 | 2016 | 5 | 0.060 |
Why?
| | WT1 Proteins | 1 | 2016 | 15 | 0.060 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2016 | 142 | 0.060 |
Why?
| | Protective Agents | 1 | 2016 | 42 | 0.060 |
Why?
| | Acetylcholine | 1 | 2016 | 203 | 0.060 |
Why?
| | Models, Immunological | 1 | 2016 | 101 | 0.060 |
Why?
| | Receptors, Interleukin-1 | 1 | 2016 | 215 | 0.060 |
Why?
| | Protozoan Proteins | 1 | 2016 | 83 | 0.060 |
Why?
| | Malaria | 1 | 2016 | 64 | 0.060 |
Why?
| | Bone Marrow Transplantation | 1 | 2016 | 292 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4319 | 0.060 |
Why?
| | Drug Synergism | 1 | 2016 | 368 | 0.060 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 326 | 0.060 |
Why?
| | Administration, Mucosal | 1 | 2014 | 2 | 0.060 |
Why?
| | Interleukin-12 Subunit p40 | 1 | 2014 | 10 | 0.060 |
Why?
| | Toll-Like Receptor 5 | 1 | 2014 | 14 | 0.060 |
Why?
| | Interleukin-1beta | 1 | 2016 | 378 | 0.050 |
Why?
| | Administration, Intranasal | 1 | 2014 | 91 | 0.050 |
Why?
| | Injections, Intravenous | 1 | 2014 | 202 | 0.050 |
Why?
| | Cross Reactions | 1 | 2014 | 130 | 0.050 |
Why?
| | Vascular Diseases | 1 | 2016 | 240 | 0.050 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2014 | 105 | 0.050 |
Why?
| | Immunologic Memory | 1 | 2016 | 357 | 0.050 |
Why?
| | Immunization | 1 | 2016 | 405 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 571 | 0.050 |
Why?
| | Mice, Inbred BALB C | 1 | 2016 | 1262 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 348 | 0.050 |
Why?
| | Fingolimod Hydrochloride | 1 | 2013 | 40 | 0.050 |
Why?
| | DNA Primers | 1 | 2014 | 509 | 0.050 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2013 | 157 | 0.050 |
Why?
| | Female | 4 | 2021 | 74071 | 0.050 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 194 | 0.050 |
Why?
| | NF-kappa B | 1 | 2016 | 678 | 0.050 |
Why?
| | Caspase 8 | 1 | 2012 | 48 | 0.050 |
Why?
| | DNA Fragmentation | 1 | 2012 | 42 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2016 | 2160 | 0.050 |
Why?
| | Candida albicans | 1 | 2012 | 55 | 0.050 |
Why?
| | Lymph Nodes | 1 | 2014 | 492 | 0.050 |
Why?
| | DNA, Neoplasm | 1 | 2012 | 158 | 0.040 |
Why?
| | bcl-2-Associated X Protein | 1 | 2011 | 56 | 0.040 |
Why?
| | Drug Resistance, Multiple | 1 | 2021 | 25 | 0.040 |
Why?
| | Fungal Proteins | 1 | 2012 | 137 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2019 | 2482 | 0.040 |
Why?
| | Mitochondrial Membranes | 1 | 2011 | 39 | 0.040 |
Why?
| | Mitochondria, Liver | 1 | 2011 | 70 | 0.040 |
Why?
| | Cell Respiration | 1 | 2021 | 103 | 0.040 |
Why?
| | Blotting, Western | 1 | 2013 | 1233 | 0.040 |
Why?
| | Biomimetic Materials | 1 | 2021 | 71 | 0.040 |
Why?
| | Base Sequence | 1 | 2014 | 2176 | 0.040 |
Why?
| | Peptides | 1 | 2016 | 980 | 0.040 |
Why?
| | Caspases | 1 | 2011 | 246 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2011 | 453 | 0.040 |
Why?
| | Molecular Structure | 1 | 2011 | 502 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 126 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2020 | 171 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2011 | 819 | 0.040 |
Why?
| | Gene Expression | 1 | 2014 | 1488 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1092 | 0.040 |
Why?
| | Cisplatin | 1 | 2011 | 327 | 0.040 |
Why?
| | Doxorubicin | 1 | 2021 | 350 | 0.040 |
Why?
| | Sulfhydryl Compounds | 1 | 2011 | 188 | 0.040 |
Why?
| | Hepatocytes | 1 | 2020 | 211 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2012 | 501 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2591 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2021 | 710 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2020 | 626 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1077 | 0.030 |
Why?
| | Nanoparticles | 1 | 2020 | 469 | 0.030 |
Why?
| | Rats | 1 | 2011 | 5594 | 0.020 |
Why?
| | Time Factors | 1 | 2013 | 6869 | 0.020 |
Why?
| | Lung | 1 | 2014 | 4107 | 0.020 |
Why?
| | Neoplasms | 1 | 2021 | 2689 | 0.020 |
Why?
| | Aged | 1 | 2020 | 24186 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 33811 | 0.010 |
Why?
| | Adult | 1 | 2020 | 38428 | 0.010 |
Why?
|
|
Valenca Pereira's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|